Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome

Journal of Physiology

Volumn 548, Issue 2, 2003, Pages 401-410

  Hittel, Dustin S ^a   Kraus, William E ^b   Hoffman, Eric P ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; DNA; FIBRIN; GENE PRODUCT; GLUCOSE; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TETRANECTIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; EXERCISE; FIBRIN CLOT; FIBRINOLYSIS; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE INDUCTION; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRACARDIAC THROMBOSIS; LONGITUDINAL STUDY; MALE; METABOLIC DISORDER; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SKELETAL MUSCLE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; SYSTEMIC CIRCULATION; ADULT; AEROBIC EXERCISE; CASE REPORT; DYSLIPIDEMIA; EXERCISE INTENSITY; GENE PRODUCT; HEART PROTECTION; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; PROTEIN INDUCTION;

ADAPTATION, PHYSIOLOGICAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FIBRIN; FIBRINOLYSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LECTINS, C-TYPE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIGENE FAMILY; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; PHYSICAL FITNESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 0038069114     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.036616     Document Type: Article

References (30)

1. American Diabetes Association (2000). Type 2 diabetes in children and adolescents. Diabetes Care 23, 381-389.
2. Bakay M, Chen YW, Borup R, Zhac, P, Nagaraju K & Hoffman EP (2002). Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics 3,4.
3. Chen YW, Nader GA, Baar KR, Fedele MJ, Hoffman EP & Esser KA (2002). Response of muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol 545, 27-41.
4. Chen YW, Zhao P, Borup R & Hoffman EP (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151, 1321-1336.
5. Carr ME (2001). Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15, 44-54.
6. Choi NS & Kim SH (2001). Two fibrin zymography methods for analysis of plasminogen activators on gels. Anal Biochem 281, 236-238.
7. el-Sayed MS (1996). Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 22, 282-298.
8. Flegal KM (1999). The obesity epidemic in children and adults: current evidence and research issues. Med Sci Sports Exerc 31, S509-S514.
9. Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL & Ledbetter SR (1995). CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem 270, 3268-3277.
10. Imhof A & Koenig W (2001). Exercise and thrombosis. Cardiol Clin 19, 389-400.
11. Iba K, Durkin ME, Johnsen L, Hunziker E, Damgaard-Pedersen K, Zhang H, Engvall E, Albrechtsen R & Wewer UM (2001). Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity. Mol Cell Biol 21, 7817-7825.
12. Kamper EF, Kopeikina L, Mantas A, Stefanadis C, Toutouzas P & Stavridis J (1998). Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment. Ann Clin Biochem 35, 400-407.
13. Kamper EF, Papaphilis AD, Angelopoulou MK, Kopeikina LT, Siakantaris MP, Pangalis GA & Stavridis JC (1999). Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clin Biochem 32, 639-645.
14. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M & Alameddine HS (1999). Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205, 158-170.
15. Kimball SR, Farrell PA & Jefferson LS (2002). Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise. J Appl Physiol 93, 1168-1180
16. Kohler HP (2002). Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Wkly 132, 241-522
17. Koller A (2002). Hemostasis and exercise. Am J Cardiol 89, 1242.
18. Kraus WE, Torgan CE, Duscha BD, Norris J, Brown SA, Cobb FR, Bales CW, Annex BH, Samsa GP, Houmard JA & Slentz CA (2001). Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc 33, 1774-1784.
19. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR & Slentz CA (2002). Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347, 1483-1492.
20. Mustonen P, Lepantalo M & Lassila R (1998). Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. Arterioscler Thromb Vasc Biol 18, 244-249.
21. Pandolfi A, Giaccari A, Polishuck R, Alberta MM, Pellegrini G, Morviducc I, L, Vitacolonna E, Buongiorn O, AM, Capani F & Consoli A (2000). Diabetis mellitus induces decreased plasma fibrinolytic activity and increased tissue synthesis of plasminogen activator inhibitor-1 (PAI-1). in the rat. Fibrinol Proteol 14, 261-267.
22. Rauramaa R & Vaisanen SB (1999). Physical activity in the prevention and treatment of a thrombogenic profile in the obese: current evidence and research issues. Med Sci Sports Exerc 31, S631-S634.
23. Rauramaa R & Vaisanen SB (2001). Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc 33, S516-S520.
24. Sakkinen PA, Wahl P, Cushman M, Lewis MR & Tracy RP (2000). Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152, 897-907.
25. Siconolfi LB & Seeds NW (2001). Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21, 4348-4355.
26. Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, Krasnoselska-Riz I, Kumar A & Pachman LM (2002). Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 68, 4154-4163.
27. Wewer UM, Iba K, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, Kuang W, Engvall E & Albrechtsen R (1998). Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol 200, 247-259.
28. Whaley MH, Kampert JB, Kohl HW 3rd & Blair SN (1999). Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med Sci Sports Exerc 31, 287-293.
29. Womack CJ, Ivey FM, Gardner AW & Macko RF (2001). Fibrinolytic response to acute exercise in patients with peripheral arterial disease. Med Sci Sports Exerc 33, 214-219.
30. Zhao P, Iezzi S, Carver E, Dressman D, Gridley T, Sartorelli V & Hoffman EP (2002). Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration. J Biol Chem 277, 30091-30101.